Study reveals insights into how cancer cells evade treatment

In the United States, cancer continues to be the second leading cause of death, trailing only heart disease, with millions more afflicted with the disease each year.

Lung cancer: Should you stop immunotherapy after 2 years?

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint - eBioMedicine

A new perspective on immune evasion: escaping immune surveillance by inactivating tumor suppressors

Radiation Therapy Imaging Technology News

How Evolution Helps Us Understand Cancer and Control It

When dormancy fuels tumour relapse

Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy - ScienceDirect

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer: Molecular Therapy - Oncolytics

Turning Toxoplasma Against Cancer

Frontiers Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers

Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma - ScienceDirect

IJMS, Free Full-Text